About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | COPD Clinical Trials in Philadelphia | 185 Studies

Clinical Trials COPDPhiladelphia

COPD Clinical Trials in Philadelphia

Find 185 clinical trials for copd near Philadelphia, Pennsylvania. Connect with research centers in your area.

All COPD trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 185 trials

TerminatedA 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)The purpose of this study is to evaluate the efficacy and the safety of two doses of CHF6001 (Tanimilast) as add-on to maintenance triple therapy in the target patient population.NCT04636814·Andalusia, Alabama and 459 others

COPD Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

CompletedLong-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease With a History of Exacerbations (PROSPERO).Subjects who completed either OBERON or TITANIA will be offered the opportunity to consent for this Multicentre, Double-blind, Randomised, Placebo controlled, Parallel Group…NCT05742802·Sheffield, Alabama and 334 others

CompletedPivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 InflammationPrimary Objective: To evaluate the efficacy of dupilumab administered every 2 weeks in patients with moderate-or severe Chronic Obstructive Pulmonary Disease (COPD) as measured…NCT03930732·Andalusia, Alabama and 274 others

CompletedA Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary DiseaseThe purpose of this study is to characterize the clinical, physiologic, and molecular profiles of healthy participants, participants with mild, moderate, and severe asthma; and…NCT01274507·Birmingham, Alabama and 20 others

CompletedEfficacy and Safety of Mepolizumab as an Add-on Treatment in Chronic Obstructive Pulmonary Disease (COPD)This is a multi-centered, randomized, placebo-controlled, double-blind, parallel group, trial evaluating 2 doses of mepolizumab against placebo given every 4 weeks through…NCT02105961·Birmingham, Alabama and 168 others

RecruitingCOPD Exacerbation Follow UpThe goal of this study is to evaluate the impact of implementing an AI-enabled clinical workflow tool (Viz COPD) on respiratory specialist follow up and clinical outcomes after an…NCT07118306·Park Ridge, Illinois and 4 others

CompletedA Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and Symbicort® pMDI 2 x 80/4.5 μg Bid With Formoterol Turbuhaler®, Budesonide pMDI, the Combination of Formoterol Turbuhaler® and Budesonide pMDI, and Placebo in COPD PatientsThe purpose of this study is to compare a combination asthma drug (Symbicort) with its two components, budesonide and formoterol, taken individually or in combination, and with…NCT00206154·Birmingham, Alabama and 211 others

RecruitingStudy of Clinical and Patient-reported Outcomes in Adults With Moderate to Severe COPD Treated With Breztri/TrixeoChronic Obstructive Pulmonary Disease is a leading cause of global morbidity and mortality, especially in low- and middle-income countries.NCT07069829·Buenos Aires and 35 others

CompletedEfficacy Safety Study of Arformoterol QD Dosing Versus BID Dosing in COPDTo evaluate the efficacy and safety of arformoterol tartrate inhalation solution 30μg/4mL QD (two 15μg/2mL dosed in combination) over a 24-hour period compared to arformoterol…NCT00571428·Medford, Oregon and 3 others

Active not recruitingVideo Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary DiseaseThe purpose of this study is to compare the efficacy and safety of a real time video telehealth pulmonary rehabilitation intervention with standard of care in patients…NCT05119556·Birmingham, Alabama and 14 others

RecruitingTemple Health Chest Initiative (THCI 2.0)Chronic obstructive pulmonary disease is highly prevalent globally, with considerable morbidity and mortality associated.NCT06933758·Philadelphia, Pennsylvania

CompletedLong Term Safety Study of NVA237 vs QAB149 in COPD PatientsThe purpose of the study is to provide long term safety data of NVA237. This study will assess the safety and tolerability of a single dose strength of NVA237.NCT01697696·Gulf Shores, Alabama and 60 others

RecruitingEfficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic PhenotypeThis is a parallel, Phase 2b/Phase 3, 3-arm study to investigate the efficacy, safety, and tolerability of subcutaneous (SC) treatment with lunsekimig compared with placebo in…NCT07190209·Chandler, Arizona and 313 others

CompletedHigh Intensity Non-Invasive Positive Pressure Ventilation (HINPPV)The purpose of this pilot study is to evaluate the effect of high intensity non-invasive positive pressure ventilation (HINPPV) for stable, hypercapnic COPD patients.NCT01214200·Philadelphia, Pennsylvania

UnknownEASE Trial: Exhale Airway Stents for EmphysemaThis is an international clinical research study evaluating the safety and effectiveness of a new procedure called airway bypass.NCT00391612·Phoenix, Arizona and 36 others

CompletedA Long-term Safety Study of Infliximab in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).The purpose of this long-term observational study is designed to collect additional information on incidence of cancer and cause of death among patients who have participated in…NCT00380796·Anaheim, California and 25 others

CompletedEfficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Patients With COPD.The primary objective of this study is to determine the optimum dose(s) of BI 1744 CL inhalation solution delivered by the Respimat® inhaler for four weeks in patients with…NCT00452400·Birmingham, Alabama and 41 others

CompletedA Comparison of SYMBICORT® pMDI With Formoterol Turbuhaler® in Subjects With COPDThe purpose of this study is to determine if SYMBICORT® delivered via a pressurized metered-dose inhaler, referred to as a pMDI, is effective in preventing COPD exacerbations.NCT00419744·Jasper, Alabama and 139 others

CompletedStudy To Assess Efficacy and Safety of Oglemilast in Patients With Chronic Obstructive Pulmonary Disease (COPD)This study will assess the safety and efficacy of a range of oglemilast doses. The study will be 14 weeks in duration.NCT00671073·Birmingham, Alabama and 46 others

CompletedTiotropium / Respimat One Year Study in COPD.The objective of the study is to evaluate the long-term (one year) efficacy and safety of tiotropium delivered by the Respimat inhaler in patients with COPD.NCT00387088·Birmingham, Alabama and 333 others

PreviousPage 2 of 10Next

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia